Hospitalization Costs of COVID-19 Cases and Their Associated Factors in Guangdong, China: A Cross-Sectional Study
Authors:
Open Access
- 11 June 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8, 655231
Abstract
Background: The ongoing COVID-19 pandemic has brought significant challenges to health system and consumed a lot of health resources. However, evidence on the hospitalization costs and their associated factors in COVID-19 cases is scarce.Objectives: To describe the total and components of hospitalization costs of COVID-19 cases, and investigate the associated factors of costs.Methods: We included 876 confirmed COVID-19 cases admitted to 33 designated hospitals from January 15th to April 27th, 2020 in Guangdong, China, and collected their demographic and clinical information. A multiple linear regression model was performed to estimate the associations of hospitalization costs with potential associated factors.Results: The median of total hospitalization costs of COVID-19 cases was $2,869.4 (IQR: $3,916.8). We found higher total costs in male (% difference: 29.7, 95% CI: 15.5, 45.6) than in female cases, in older cases than in younger ones, in severe cases (% difference: 344.8, 95% CI: 222.5, 513.6) than in mild ones, in cases with clinical aggravation than those without, in cases with clinical symptoms (% difference: 47.7, 95% CI: 26.2, 72.9) than those without, and in cases with comorbidities (% difference: 21.1%, 21.1, 95% CI: 4.4, 40.6) than those without. We also found lower non-pharmacologic therapy costs in cases treated with traditional Chinese medicine (TCM) therapy (% difference: −47.4, 95% CI: −64.5 to −22.0) than cases without.Conclusion: The hospitalization costs of COVID-19 cases in Guangdong were comparable to the national level. Factors associated with higher hospitalization costs included sex, older age, clinical severity and aggravation, clinical symptoms and comorbidities at admission. TCM therapy was found to be associated with lower costs for some non-pharmacologic therapies.Keywords
This publication has 26 references indexed in Scilit:
- Traditional Chinese medicine for COVID-19 treatmentPharmacological Research, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Characteristics of COVID-19 infection in BeijingJournal of Infection, 2020
- The Global Macroeconomic Impacts of COVID-19: Seven ScenariosSSRN Electronic Journal, 2020
- Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysisTravel Medicine and Infectious Disease, 2020
- Multicollinearity and misleading statistical resultsKorean Journal of Anesthesiology, 2019
- ImmGen report: sexual dimorphism in the immune system transcriptomeNature Communications, 2019
- Parental Type D Personality and Children’s Hyperactive Behaviors: The Mediating Role of Parent–Child Interactive ActivitiesInternational Journal of Environmental Research and Public Health, 2019
- Does Level of Hospital Matter? A Study of Mortality of Acute Myocardial Infarction Patients in Shanxi, ChinaAmerican Journal of Medical Quality, 2017
- Chinese Herbal Medicine for Severe Acute Respiratory Syndrome: A Systematic Review and Meta-AnalysisThe Journal of Alternative and Complementary Medicine, 2004